Safety Stem Cells in Spinal Cord Injury

Summary

Mono-center, open label study to investigate the safety of Neuro-Cells in 10 end stage (chronic) traumatic spinal cord injury (TSCI) patients, when administered once intrathecally. TSCI is a rare disease without cure perspectives and Neuro-Cells is an autologous fresh stem cells containing product (one batch / one patient).

Timeline

Start

2020-11-14

Primary completion

2021-06-18

Completion

2023-03-10

Drugs

Indications